A clinical trial on the effect of lactulose on mineral absorption.

Not Applicable

• Conditions: one

• Registration Number: JPRN-UMIN000052813
• Lead Sponsor: KSO Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-17
• Last Update Posted: 22 January 2024
• Study Completion: 2024-03-31

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1)Subjects undergoing treatment for liver, kidney, heart, lung, gastrointestinal, hematological, endocrine, and infectious diseases, or those with a serious history of these diseases. 2)Subjects with a history of gastrointestinal resection (excluding appendicitis). 3)Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease. 4)Subjects who regularly use medicine that affect the gut microbiota or bone metabolism (antibiotics, active biopharmaceuticals, laxatives, active vitamin D3, etc.) 5)Subjects who regularly use food with functional claims that improve the gut microbiota or maintain bone density or improve bone metabolism or promote mineral absorption, or foods containing vitamin D3 or mineral. 6)Subjects with serious allergies to medicines and food. 7)Subjects with lactose intolerance. 8)Subjects who participate in another clinical study within 3months before providing written consent to participate in the present study. 9)Subjects who are judged inappropriate for the study by principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified